company background image
OSL logo

OncoSil Medical ASX:OSL Stock Report

Last Price

AU$0.005

Market Cap

AU$9.9m

7D

-16.7%

1Y

-54.5%

Updated

29 Mar, 2024

Data

Company Financials

OSL Stock Overview

OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide.

OSL fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

OncoSil Medical Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for OncoSil Medical
Historical stock prices
Current Share PriceAU$0.005
52 Week HighAU$0.015
52 Week LowAU$0.005
Beta0.42
1 Month Change-37.49%
3 Month Change-44.44%
1 Year Change-54.54%
3 Year Change-94.68%
5 Year Change-91.07%
Change since IPO-97.50%

Recent News & Updates

Recent updates

Companies Like OncoSil Medical (ASX:OSL) Could Be Quite Risky

May 24
Companies Like OncoSil Medical (ASX:OSL) Could Be Quite Risky

Here's Why We're Watching OncoSil Medical's (ASX:OSL) Cash Burn Situation

Feb 03
Here's Why We're Watching OncoSil Medical's (ASX:OSL) Cash Burn Situation

Is OncoSil Medical (ASX:OSL) In A Good Position To Deliver On Growth Plans?

Oct 20
Is OncoSil Medical (ASX:OSL) In A Good Position To Deliver On Growth Plans?

OncoSil Medical (ASX:OSL) Is In A Good Position To Deliver On Growth Plans

May 13
OncoSil Medical (ASX:OSL) Is In A Good Position To Deliver On Growth Plans

OncoSil Medical's (ASX:OSL) Stock Price Has Reduced 42% In The Past Five Years

Mar 21
OncoSil Medical's (ASX:OSL) Stock Price Has Reduced 42% In The Past Five Years

We're Not Worried About OncoSil Medical's (ASX:OSL) Cash Burn

Jan 26
We're Not Worried About OncoSil Medical's (ASX:OSL) Cash Burn

How Much Did OncoSil Medical's(ASX:OSL) Shareholders Earn From Share Price Movements Over The Last Year?

Dec 04
How Much Did OncoSil Medical's(ASX:OSL) Shareholders Earn From Share Price Movements Over The Last Year?

Shareholder Returns

OSLAU Life SciencesAU Market
7D-16.7%3.3%1.3%
1Y-54.5%-22.8%11.5%

Return vs Industry: OSL underperformed the Australian Life Sciences industry which returned -22.8% over the past year.

Return vs Market: OSL underperformed the Australian Market which returned 11.5% over the past year.

Price Volatility

Is OSL's price volatile compared to industry and market?
OSL volatility
OSL Average Weekly Movement25.4%
Life Sciences Industry Average Movement10.0%
Market Average Movement8.8%
10% most volatile stocks in AU Market17.1%
10% least volatile stocks in AU Market3.2%

Stable Share Price: OSL's share price has been volatile over the past 3 months.

Volatility Over Time: OSL's weekly volatility has increased from 19% to 25% over the past year.

About the Company

FoundedEmployeesCEOWebsite
2005n/aNigel Langehttps://www.oncosil.com.au

OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia.

OncoSil Medical Limited Fundamentals Summary

How do OncoSil Medical's earnings and revenue compare to its market cap?
OSL fundamental statistics
Market capAU$9.87m
Earnings (TTM)-AU$11.71m
Revenue (TTM)AU$1.30m

7.6x

P/S Ratio

-0.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
OSL income statement (TTM)
RevenueAU$1.30m
Cost of RevenueAU$1.87m
Gross Profit-AU$573.73k
Other ExpensesAU$11.13m
Earnings-AU$11.71m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.0059
Gross Margin-44.18%
Net Profit Margin-901.58%
Debt/Equity Ratio0%

How did OSL perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.